EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Viral Hepatitis Elimination 2022

 

24–25 February 2022
Close
N. Poster
Poster title
Applicant name
Status
  PO-07 Clinical and epidemiological characteristics of Chronic Viral Hepatitis in Kazakhstan: data from Unified Nationwide Electronic Healthcare System 2014-2019 Dmitriy Syssoyev Received Received
  PO-18 Are men who have sex with men (MSM) in Europe protected from Hepatitis A and B? Results from the European MSM internet survey (EMIS-2017) Michael Brandl Received Received
  PO-21 HCV micro-elimination strategies for the PWUD population of the Balearic Islands Jeffrey Lazarus Received Received
  PO-26 Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands Cas Isfordink Received Received
  PO-27 The prevalence of Hepatitis B in the UK: a systematic review Sema Mandal Received Received
  PO-28 Mortality rates among individuals with laboratory diagnosed hepatitis B virus (HBV) infection: England, 1999-2018 Sema Mandal Received Received
  PO-36 A model for a pharmacist-led point-of-care hepatitis C treatment service in outreach settings Jacob Smiles Received Received
  PO-39 Immunity to hepatitis A and hepatitis B among men who have sex with men (MSM) attending sexual health clinics in London and the North of England, 2017-18 Sema Mandal Received Received
  PO-52 The Mobile pathway, an opportunity in providing Hepatitis C services, during the challenging times of COVID-19 Anne Manjalee Liyanage Received Received
  PO-56 Antenatal hepatitis C testing and care in maternity services in England, a national survey Amoolya Vusirikala Received Received
  PO-57 Primary care physician adoption of hepatitis C virus treatment in United States Medicaid programs Shashi Kapadia Received Received
  PO-63 FIB-5 and/or FIB-4 index for hepatic fibrosis assessment in chronic hepatitis B patients Mohamed Abdel-Samiee Received Received
  PO-64 Trends in hepatitis C treatment and chronic prevalence over the last decade among people who inject drugs Eva Emanuel Received Received
  PO-66 FOCUS Project: preliminary results toward Hepatitis C Virus screening and elimination in Almería, Spain Anny Camelo Castillo Received Received
  PO-69 Screening for hepatitis C virus reinfection using a behaviour-based risk score among HIV-positive men who have sex with men Kris Hage Received Received
  PO-73 Combined COVID-19 vaccination and hepatitis C virus and HIV screening intervention for high-risk populations at a mobile testing unit in Madrid, Spain Jeffrey V Lazarus Received Received
  PO-75 Demonstrating control of perinatal transmission of hepatitis B in the UK: a low prevalence country with universal antenatal screening and ive neonatal immunisation programmes Sema Mandal Received Received
  PO-76 Community values and preferences regarding decentralisation and task-shifting of HCV services - results from an international online survey Cary James Received Received
  PO-78 Demographic characteristics and viral diversity in hepatitis B infected pregnant women in England: implications for control of maternal to child transmission Eleanor Clarke Received Received
  PO-82 Enhancing Universal Hepatitis B and C Screening via the Electronic Medical Record: A Case Study Mageras Anna Received Received
  PO-84 Outcome of Hepatitis C Virus co-infection treatment among Human Immunodeficiency Virus-infected people who inject drugs: an Egyptian real-life experience. ahmed cordie Received Received
  PO-88 Approaches for a Hepatitis C-free city: preliminary results Angelica Luque Received Received
  PO-89 Direct acting antiviral treatment for chronic hepatitis C are successful in Egyptian patients with chronic hepatitis C virus infection after a geographically focused, community-based HCV screening Mohamed Abdel-Samiee Received Received
  PO-92 Hepatitis C virus micro-elimination approach in vulnerable population in the South of Spain Jesús Aranda López Received Received
  PO-94 Screening for hepatitis C virus in high risk categories of Romanian population and updated prevalence data Speranta Iacob Received Received
  PO-97 Microelimination of Hepatitis C in patients with substance use disorders Ruben Carvalho Received Received
  PO-98 Screening for hepatitis B virus in high risk categories of Romanian population and updated prevalence data Speranta Iacob Received Received
  PO-99 No reinfections: elimination is feasible in drug adicctions users Esther Rodríguez Candelaria Received Received
  PO-105 Safety and efficacy of crushed sofosbuvir/velpatasvir in hepatitis C infected patients - a case series Shobha Joshi Received Received
  PO-107 Going, going, gone? Routine Emergency Department hepatitis C testing can drive and monitor elimination Kate Drysdale Received Received
  PO-111 Estimated prevalence of chronic hepatitis B in Denmark Signe Bollerup Received Received
  PO-112 Framework for hepatitis C virus (HCV) Micro-Elimination in Ho Chi Minh City (HCMC), Vietnam: A Path to National HCV Elimination Thanh Kim Received Received
  PO-113 Is it possible a real Point-Of-Care? Feasibility evaluation of telemedicine project to overcome the last barriers to treatment in PWIDs. Daniela Maggi Received Received
  PO-114 Characteristics of childhood hepatitis B diagnosed cases reported to the national enhanced surveillance system, England 2017-2021 Eleanor Clarke Received Received
  PO-115 HCV elimination among People Who Use Drug in Rome outside the hospital setting is possible during the COVID19 pandemic. Elisabetta Teti Received Received
  PO-117 What can Europe learn from HCP knowledge and attitudes towards hepatitis A vaccination in the US? Anar ANDANI Received Received
  PO-118 Point of care screening tests for hepatitis B and commitment of a dedicated nurse lead to successful linkage to care of ethnic minorities Axelle Vanderlinden Received Received
  PO-121 A model for detection and linkage to care of hepatitis C infected persons in prisons in Croatia Lucija Virovic Jukic Received Received
  PO-122 The Elimination of hepatitis C by the Cherokee Nation Jorge Mera Received Received
  PO-123 implementing a simplified model of care for hepatitis c virus micro-elimination among people living with human immunodeficiency virus who inject drugs in Egypt Rahma Mohamed Received Received
  PO-124 a single centre 2020 view of blood borne viruses and risk behaviour in male irish prisoners CATHAL CLIFFORD Received Received
  PO-128 Evidence of hepatitis B virus (HBV) horizontal transmission and a significant proportion of adults remaining at high risk of horizontal HBV transmission are barriers to HBV elimination in Ho Chi Minh City (HCMC), Vietnam Thanh Kim Received Received
  PO-136 Hepatitis C virus in people who inject drugs at the Needle and Syringe Program in Uppsala, Sweden Elsa Kagstrom Received Received
  PO-137 Phyloepidemiological analysis of antiviral resistance to NS5A inhibitors in subtype 1a in England post-rollout of direct acting antivirals Daniel Bradshaw Received Received
  PO-138 Combined telephone and home assessment and home treatment delivery improves drug service client access to hepatitis c care and treatment uptake during the COVID-19 pandemic Natasha Baker Received Received
  PO-139 Hepatitis B virus vaccination among people with human immunodeficiency virus in the Netherlands Anders Boyd Received Received
  PO-140 Update on hepatitis A in Europe a systematic review on outbreaks and burden of disease in 11 countries, 20012021 Kassiani Mellou Received Received
  PO-141 Covid-19 pandemic: a significant barrier for hepatitis c elimination for people who use drugs (PWUD) in Greece Pinelopi Antonakaki Received Received
  PO-143 Estimating rates of hepatitis C virus reinfection among patients receiving antiviral treatment in England Matthew Hibbert Received Received
  PO-144 Hepatitis C virus test positivity among pregnant women in England between 2016-2017 Matthew Hibbert Received Received
  PO-147 Seroprevalence of vaccine derived Hepatitis B antibodies in Germany: results from the German Health Survey for Children and Adolescents, 2014-2017 Ida Sperle Received Received
  PO-149 Implementation of rapid point-of-care diagnostic systems to support HCV micro-elimination strategies in a tertiary hospital in Spain. Antonio Madejón Received Received
  PO-150 Clinical characteristics and survival of patients with cirrhosis and hepatocellular carcinoma in The Gambia Erwan Vo Quang Received Received
  PO-155 How should reinfection rates be measured and presented? Pitfalls and practical lessons from the Trap HepC project Magnus Gottfredsson Received Received
  PO-161 Effectiveness of non-nurse, non-doctor Community Liaison Officer programme in testing and treating hepatitis C in homeless populations F Javier Vilar Received Received
  PO-167 National Hepatitis Elimination Profiles: Progress Towards HBV and HCV Elimination in the Americas Vanessa Nunez Received Received
  PO-168 Hepatitis C virus treatment uptake among marginalized people who inject drugs: a registry based study Kristian Malme Received Received
  PO-172 The Canadian real-world 8 years experience with DAA-based regimens in genotype 3: Preliminary data Isaac Ruiz Received Received
  PO-179 Hepatitis C screening in a psychiatric emergency department: 8-months results Ana Barreira Received Received
  PO-183 TESTATE C Plus: an online self-sampling intervention for hepatitis C in gay, bisexual and other men who have sex with men and trans women in Spain Cristina Agustí Received Received
  PO-195 To reconvene patients who were lost to follow-up is a useful strategy to eliminate Hepatitis C Virus. Results from the multicenter French study RECONVOCC. Armand Abergel Received Received
  PO-199 Hepatitis A and B Infection and Vaccination among MSM in Ireland: an Analysis of the Findings from the European MSM Internet Survey 2017 (EMIS-2017) Philippa White Received Received
  PO-202 Lack of Hepatitis B vaccination among high-risk populations: A single-center study in an addiction treatment center Franois Villeret Received Received
  PO-203 Mind the Gap: Preliminary evaluation of the prevention of mother-to-child transmission of Hepatitis B care cascade in rural western Uganda Sahal Thahir Received Received
  PO-204 Contact tracing in networks of people who inject drugs with Hepatitis C is the most efficient testing strategy to maintain Hepatitis C elimination post 2030 RYan Buchanan Received Received
  PO-207 Targeted immunotherapy with heterologous prime-boost and adjuvanted hepatitis B core (HBc)/surface (HBs) proteins in adult chronic hepatitis B patients showed positive HBc- and HBs-specific CD8 and CD4 T cell responses in a phase I/II trial Kristien Swinnen Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
18:10
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

Viral Hepatitis Elimination 2022

 

24–25 February 2022
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 24/02/2022 TO 24/02/2023
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert